221 related articles for article (PubMed ID: 25088385)
21. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[TBL] [Abstract][Full Text] [Related]
22. Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank.
Nevado-Holgado AJ; Kim CH; Winchester L; Gallacher J; Lovestone S
BMJ Open; 2016 Nov; 6(11):e012177. PubMed ID: 27903560
[TBL] [Abstract][Full Text] [Related]
23. Warfarin-fluoxetine and diazepam-fluoxetine interaction.
Dent LA; Orrock MW
Pharmacotherapy; 1997; 17(1):170-2. PubMed ID: 9017779
[TBL] [Abstract][Full Text] [Related]
24. Hypotension secondary to the combination of intramuscular olanzapine and intramuscular lorazepam.
Zacher JL; Roche-Desilets J
J Clin Psychiatry; 2005 Dec; 66(12):1614-5. PubMed ID: 16401168
[No Abstract] [Full Text] [Related]
25. Association of Opioids and Sedatives with Increased Risk of In-Hospital Cardiopulmonary Arrest from an Administrative Database.
Overdyk FJ; Dowling O; Marino J; Qiu J; Chien HL; Erslon M; Morrison N; Harrison B; Dahan A; Gan TJ
PLoS One; 2016; 11(2):e0150214. PubMed ID: 26913753
[TBL] [Abstract][Full Text] [Related]
26. An assessment of quality of sleep and the use of drugs with sedating properties in hospitalized adult patients.
Frighetto L; Marra C; Bandali S; Wilbur K; Naumann T; Jewesson P
Health Qual Life Outcomes; 2004 Mar; 2():17. PubMed ID: 15040803
[TBL] [Abstract][Full Text] [Related]
27. Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017.
Vold JH; Skurtveit S; Aas C; Chalabianloo F; Kloster PS; Johansson KA; Fadnes LT
BMC Health Serv Res; 2020 Apr; 20(1):352. PubMed ID: 32334602
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
29. [Remote consequences of the long-term uncontrolled use of anxiolytic and hypnotic drugs by elderly patients: cognitive disorders].
Ivanets NN; Kinkulkina MA; Avdeeva TI; Sysoeva VP
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):50-64. PubMed ID: 26978494
[TBL] [Abstract][Full Text] [Related]
30. Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults.
Musich S; Wang SS; Slindee LB; Ruiz J; Yeh CS
Popul Health Manag; 2020 Aug; 23(4):286-296. PubMed ID: 31765280
[TBL] [Abstract][Full Text] [Related]
31. Insomnia: Pharmacologic Treatment.
Lou BX; Oks M
Clin Geriatr Med; 2021 Aug; 37(3):401-415. PubMed ID: 34210446
[TBL] [Abstract][Full Text] [Related]
32. Sedative use and incident cognitive decline among persons aged 75 years and older: a population-based longitudinal study.
Desplenter F; Lavikainen P; Hartikainen S; Sulkava R; Bell JS
Int Psychogeriatr; 2012 Jan; 24(1):48-54. PubMed ID: 21843400
[TBL] [Abstract][Full Text] [Related]
33. The use of sedative/hypnotic medication and its correlation with falling down in the hospital.
Mendelson WB
Sleep; 1996 Nov; 19(9):698-701. PubMed ID: 9122555
[TBL] [Abstract][Full Text] [Related]
34. Number and dosage of central nervous system medications on recurrent falls in community elders: the Health, Aging and Body Composition study.
Hanlon JT; Boudreau RM; Roumani YF; Newman AB; Ruby CM; Wright RM; Hilmer SN; Shorr RI; Bauer DC; Simonsick EM; Studenski SA
J Gerontol A Biol Sci Med Sci; 2009 Apr; 64(4):492-8. PubMed ID: 19196642
[TBL] [Abstract][Full Text] [Related]
35. Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine users.
Bénard-Laribière A; Noize P; Pambrun E; Bazin F; Verdoux H; Tournier M; Bégaud B; Pariente A
Eur J Clin Pharmacol; 2016 Jul; 72(7):869-76. PubMed ID: 27023467
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioning.
Koch E; Johnell K; Kauppi K
Pharmacoepidemiol Drug Saf; 2023 Apr; 32(4):446-454. PubMed ID: 36357173
[TBL] [Abstract][Full Text] [Related]
37. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Von Korff M; Jackson LA
J Am Geriatr Soc; 2011 Oct; 59(10):1899-907. PubMed ID: 22091503
[TBL] [Abstract][Full Text] [Related]
38. [Comparative analysis of antiarrhythmic and proarrhythmogenic effects of drugs for neuroleptanalgesia, ataralgesia, and antidepranalgesia in experimental acute myocardial infarction].
Iakushev AM; Iakushev MP; Sapozhkov AV
Eksp Klin Farmakol; 2006; 69(4):28-31. PubMed ID: 16995434
[TBL] [Abstract][Full Text] [Related]
39. Use of benzodiazepines and cognitive performance in primary care patients with first cognitive complaints.
Grande G; Tramacere I; Vetrano DL; Pomati S; Mariani C; Filippini G
Int Psychogeriatr; 2018 Apr; 30(4):597-601. PubMed ID: 29117880
[TBL] [Abstract][Full Text] [Related]
40. Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.
Gudin JA; Mogali S; Jones JD; Comer SD
Postgrad Med; 2013 Jul; 125(4):115-30. PubMed ID: 23933900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
